Veriheal

MARCH 6, 2024

Department of Health and Human Services (HHS) recommended that the Drug Enforcement Agency (DEA) reshedule cannabis as a Schedule III substance in August of 2023. The HSS found strong scientific support regarding cannabis’ medically beneficial effects for conditions like anorexia , nausea, and chronic pain.

Research and Development 62

Research and Development DEA Chronic Pain Business 62

Veriheal

NOVEMBER 11, 2023

According to the United States Drug Enforcement Administration (DEA), Schedule One drugs are “drugs with no currently accepted medical use and a high potential for abuse.” Common challenges that veterans face include chronic pain, PTSD, depression, insomnia, traumatic brain injury, broken bones, and musculoskeletal ailments.

Law 62

Law Chronic Pain Conditions Legislation 62

The Joint Blog

JUNE 4, 2021

Those state laws allow medical marijuana to be used to treat ailments like Alzheimer’s, cancer, epilepsy, Crohn’s disease, seizures, hepatitis C and a host of others. The United States Food and Drug Administration (FDA) has only cannabis use to treat two rare and severe forms of epilepsy: Dravet syndrome and Lennox-Gastaut syndrome.

Conditions 32

Conditions Chronic Pain Marijuana Research and Development 32

Veriheal

DECEMBER 28, 2021

D espite the Drug Enforcement Agency’s (DEA) announcement in May that it would soon start reviewing grower applications for research purposes, cannabis research continues to be tightly restricted. Chronic pain. Amyotrophic lateral sclerosis (ALS). Alzheimer’s. Depression. Multiple Sclerosis. Tourette Syndrome.

Research and Development 93

Research and Development Chronic Pain Treatment Medicine 93

MedicalJane

JUNE 29, 2018

Pennsylvania’s neighboring state, Maryland , has a much shorter list of qualifying medical conditions: cachexia, anorexia, wasting syndrome, severe pain or nausea or persistent muscle spasms, seizures, glaucoma, PTSD, and chronic pain. Can your current doctor “prescribe” cannabis?

Patients 83

Patients Legalization Conditions Treatment 83

Veriheal

AUGUST 31, 2020

Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Supply chains are disrupted as a result, and consumers grow fearful of buying hemp.

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

SEPTEMBER 23, 2019

26 Evidence is most substantial for nausea and vomiting associated with chemotherapy, chronic pain treatment, multiple sclerosis spasticity, and intractable seizures associated with Dravet syndrome and Lennox-Gastaut syndrome. Cannabinoids have been assessed for chronic pain management.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40